A

Advanced Clinical Research, LLC | Miami, FL

Research site

(Unclaimed)

Location

8600 SW 92nd Street Suite: 104, Miami, Florida, United States of America

Site insights

Top conditions

Top treatments

Bococizumab

Bupropion Hydrochloride

BOS-580

HU6

Methotrexate

Naltrexone Hydrochloride

ACP-204

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 7 total trials

A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout

The primary objective of this trial is to evaluate the effect of pegloticase 18 mg subcutaneously (SC) every two weeks with methotrexate (MTX) versus...

Enrolling

Uncontrolled Gout

Drug: Pegloticase

Drug: Methotrexate

ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study

This 52-week, open-label extension study is to evaluate the long-term safety and tolerability of ACP-204 in subjects with ADP.

Invitation-only

Alzheimer's Disease Psychosis

Drug: ACP-204

Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE) (INFORMUS)

A randomized, double-blinded, placebo controlled study intended to capture cardiovascular outcomes during real-world use of naltrexone/bupropion (NB).

Enrolling

Obesity

Drug: Placebo

Drug: Naltrexone-Bupropion (NB) Combination

Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis

This is a phase 2 randomized, double-blind, placebo-controlled parallel group study of 3 dose levels of HU6 in subjects with nonalcoholic steatohepat...

Active, not recruiting

Fatty Liver

Nonalcoholic Steatohepatitis

Drug: HU6

Other: Placebo